3
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Antitumor Effect of the New Rhodium(II) Complex: Rh2 (Form)2 (02 CCF3)2 (H20)2 (Form = N,N’-di-p-tolylformamidinate)

, , &
Pages 319-326 | Published online: 14 Jul 2016

References

  • Rosenberg B, Van Camp L, Trosko JE, Mansour Vii. Platinum compounds: a new class of potent antitumor agents. Nature 1969; 222: 385–386.
  • Casper ES, Kelsen DP, Alcock NW, Lewis JL Jr. I.p. cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the i.v. route. Cancer Treat Rep 1983; 67: 235–241.
  • Cleare MJ. Transition metal complexes in cancer chemotherapy. Coord Chem Rev 1974; 12: 349–405.
  • Einhorn LH, Furnas B. Improved chemotherapy in disseminated testicular cancer. J Clin Hematol Oncol 1977; 7: 662–665.
  • Young RC, Von Hoff DD, Gormely P, Makuch R, Cassidy J, Howser D, Bull JM. Cis-dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer. Cancer Treat Rep 1979; 63: 1539–1543.
  • Harrap KR, Jones M, Wilkinson CR. Antitumor, toxic and biochemical properties of cisplatin and eight other platinum complexes. In: Prestayko AW, Crooke ST, Carter SK, eds. Cisplatin current status and new developments. New York: Academic Press, 1980: 193–211.
  • Leonard BJ, Eccleston E, Jones D, Todd P, Walpole A. Antileukemic nephrotoxic properties of platinum. Nature 1971; 234: 43–45.
  • Kopf-Maier P, Kopf H. Non-platinum-group metal antitumor agents: history, current status and perspectives. Chem Rev 1987; 87: 1137–1152.
  • Sava G, Giraldi T, Mestroni G, Zassinovich G. Antitumor effects of Rhodium(I), Iridium(I) and Ruthenium(II) complexes in comparison with cis-dichlorodiammineplatinum(II) in mice bearing Lewis lung carcinoma. Chem Biol Interact 1983; 45: 1–7.
  • Bear JL, Gray HB, Rainen L, Chang I-M, Howard R, Serio G, Kimball AP. Interaction of Rhodium(II) carboxylates with molecules of biologic importance. Cancer Chemother Rep 1975; 59: 611–620.
  • Erck A, Raineri L, Whileyman J, Chang I-M, Kimball AP, Bear J. Studies of Rhodium(II) carboxylates as potential antitumor agents. Proc Soc Exptl Biol Med 1974; 145: 1278–1283.
  • Piraino P, Bruno G, Tresoldi G, Lo Schiavo S, Zanello P. Chemical oxidation of binuclear rhodium(I) complexes with silver salts. Synthesis, X-ray crystal structure, and electrochemical properties of the Rh24 + mixed-ligand complex Rh2 (Form)2(02CCF3)2 (H20)2 0.5C6H6(Form= N,N’-di-ptolylformamidinate anion). Inorg Chem 1987; 26: 91–96.
  • Fimiani V. In vivo effect of didemnin B on two tumors of the rat. Oncology 1987; 44: 42–46.
  • Erck A, Sherwood E, Bear JL, Kimball AP. The metabolism of rhodium(II) acetate in tumor-bearing mice. Cancer Res 1976; 36: 2204–2209.
  • Amato A, Fimiani V, Bottari C, Cavallaro A. Proliferation kinetics of Yoshida ascites tumor growth. Acta Oncol 1984; 5: 1–6.
  • Ashihara T. Analysis of incipient growth of Yoshida sarcoma in vivo after transplantation of a small number of tumor cells. Gann 1976; 67: 75–79.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.